Automated cell manufacturing company Mytos has partnered with Aspen Neuroscience to automate the production of customized cells for Aspen’s Parkinson’s disease therapy. Under the agreement, Aspen will use Mytos’s iDEM technology to manage cell production in its California-based factory. The deal allows Aspen to streamline its cell production process, reducing labor and enabling multibatch handling to increase capacity. A manual iDEM alternative can be learned by a single operator.
Cybersecurity Threats to Health Systems Getting More Aggressive: Experts
In a recent live webinar hosted by Newsweek, health care experts discussed increasing cyber threats to the sector, which saw 677 attacks in the last
